Unixam

Unixam (Tranexamic Acid) is an antifibrinolytic medication used to reduce or prevent excessive bleeding. It works by slowing the breakdown of blood clots. Commonly prescribed for surgical or trauma-related blood loss. Suitable for intravenous administration in clinical settings.

Tranexamic Acid, the active ingredient in Unixam, is primarily used to control heavy bleeding by preventing clot breakdown. It is often prescribed before or after surgeries, for heavy menstrual bleeding, or in cases of trauma where blood loss needs to be minimized. The medication supports the body’s natural clotting process without altering normal blood function.

Unixam helps maintain stable blood clots, reducing the risk of prolonged bleeding during medical procedures or after injury. Patients may notice less bruising or swelling due to its clot-stabilizing properties. The effects are typically observed shortly after administration and are intended to support the body’s natural response to bleeding.

Unixam should only be used under medical supervision due to the risk of clotting complications. Patients with a history of blood clots, kidney disease, or certain heart conditions should inform their healthcare provider before use. Regular monitoring may be required to ensure safe administration. Always follow prescribed guidelines for intravenous use.

Unixam may interact with medications that affect blood clotting, such as anticoagulants or hormonal contraceptives. Combining it with certain drugs, including some antibiotics or antifungals, could alter its effectiveness. Alcohol and smoking may also influence how the body processes the medication. Always disclose all current medications to your healthcare provider.